Marli Matiko Anraku de Campos

Dr. Marli Matiko Anraku de Campos

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in Clinical Biochemistry
Verified
Journal Article
Closed access
ETEtiane Tatsch
Etiane Tatsch
GBGuilherme Vargas Bochi
Guilherme Vargas Bochi
RPRenata da Silva Pereira
Renata da Silva Pereira
HKHelena Kober
Helena Kober
VAVanessa Albertina Agertt
Vanessa Albertina Agertt
RMRafael Noal Moresco
Rafael Noal Moresco

1 December 2013 in American Journal of Infection Control
Verified
Journal Article
Closed access
PBPauline Cordenonsi Bonez
Pauline Cordenonsi Bonez
CACamilla Filippi dos Santos Alves
Camilla Filippi dos Santos Alves
TDTanise Vendruscolo Dalmolin
Tanise Vendruscolo Dalmolin
VAVanessa Albertina Agertt
Vanessa Albertina Agertt
CMCaren Rigon Mizdal
Caren Rigon Mizdal
MCMarli Matiko Anraku de Campos
Marli Matiko Anraku de Campos

1 February 2015 in Journal of Applied Biomedicine
Verified
Journal Article
Closed access
ABAline Augusti Boligon
Aline Augusti Boligon
MPMariana Piana
Mariana Piana
TKThaís Felli Kubiça
Thaís Felli Kubiça
DMDébora Nunes Mario
Débora Nunes Mario
TDTanise Vendruscolo Dalmolin
Tanise Vendruscolo Dalmolin
MAMargareth Linde Athayde
Margareth Linde Athayde

13 August 2018 in Food Science & Nutrition
Verified
Journal Article
Open access
PDF file
ABAjiboye Basiru
Ajiboye Basiru
Oluwafemi Adeleke OjoOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo
MOMarry A. Okesola
Marry A. Okesola
AAAyodele J. Akinyemi
Ayodele J. Akinyemi
JTJustina Y. Talabi
Justina Y. Talabi
MCMarli Matiko Anraku de Campos
Marli Matiko Anraku de Campos
The phenolic extract of Senecio biafrae leaves was investigated to determine the in vitro antioxidant, phenolic profiles, and inhibition of key enzymes relevant to type II diabetes mellitus (α‐amylase and α‐glucosidase) and Alzheimer's disease (acetylcholinesterase and butrylcholinesterase). The phenolic extract demonstrated significant scavenging abilities against all in vitro antioxidant parameters assessed. Reversed‐phase HPLC of the extract revealed the presence of gallic acid, chlorogenic, caffeic acid, rutin, quercetin, and kaempferol. The extract also inhibited activities of α‐amylase (IC50 = 126.90 μg/ml), α‐glucosidase (IC50 = 139.66 μg/ml), acetylcholinesterase (IC50 = 347.22 μg/ml), and butrylcholinesterase (IC50 = 378.79 μg/ml), which may be attributed to the antioxidant potential of the extract and its phenolic composition. Therefore, this study suggests that the leaves of S. biafrae may be useful in the management of diabetes mellitus and Alzheimer's disease.

1 April 2018 in Brazilian Journal of Microbiology
Verified
Journal Article
Open access
RJRoberta Jesus
Roberta Jesus
MPMariana Piana
Mariana Piana
RFRobson B Freitas
Robson B Freitas
TBThiele F Brum
Thiele F Brum
CACamilla F S Alves
Camilla F S Alves
LBLiliane Bauermann
Liliane Bauermann
The main objective of this study was to demonstrate the antimicrobial potential of the crude extract and fractions of Chenopodium ambrosioides L., popularly known as Santa-Maria herb, against microorganisms of clinical interest by the microdilution technique, and also to show the chromatographic profile of the phenolic compounds in the species. The Phytochemical screening revealed the presence of cardiotonic, anthraquinone, alkaloids, tannins and flavonoids. The analysis by HPLC-DAD revealed the presence of rutin in the crude extract (12.5±0.20mg/g), ethyl acetate (16.5±0.37mg/g) and n-butanol (8.85±0.11mg/g), whereas quercetin and chrysin were quantified in chloroform fraction (1.95±0.04 and 1.04±0.01mg/g), respectively. The most promising results were obtained with the ethyl acetate fraction, which inhibited a greater number of microorganisms and presented the lowest values of MIC against Staphylococcus aureus and Enterococcus faecalis (MIC=0.42mg/mL), Pseudomonas aeruginosa (MIC=34.37mg/mL), Paenibacillus apiarus (MIC=4.29mg/mL) and Paenibacillus thiaminolyticus (MIC=4.29mg/mL). Considering mycobacterial inhibition, the best results were obtained by chloroform fraction against M. tuberculosis, M. smegmatis, and M. avium (MIC ranging from 156.25 to 625μg/mL). This study proves, in part, that the popular use of C. ambrosioides L. can be an effective and sustainable alternative for the prevention and treatment of diseases caused by various infectious agents.

1 January 2017 in Toxicology Research
Verified
Journal Article
Open access
PDF file
NCNélson R. de Carvalho
Nélson R. de Carvalho
NRNathane R. Rodrigues
Nathane R. Rodrigues
GMGiulianna E. Macedo
Giulianna E. Macedo
IBIvi J. Bristot
Ivi J. Bristot
ABAline A. Boligon
Aline A. Boligon
JFJeferson L. Franco
Jeferson L. Franco
We evaluate the effects of Eugenia uniflora essential oil on mitochondrial bioenergetics in Drosophila melanogaster.